Publicaciones en colaboración con investigadores/as de Hospital de São João (63)

2020

  1. Ibero-latinamerican clinical practical guidelines on pediatric caustic esophagitis: Physiopathology and clinical-endoscopic diagnosis (1st part)

    Revista Chilena de Pediatria, Vol. 91, Núm. 1, pp. 149-157

  2. Long-term effects of medical management on growth and weight in individuals with urea cycle disorders

    Scientific Reports, Vol. 10, Núm. 1

  3. Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers

    Endocrine Pathology, Vol. 31, Núm. 3, pp. 197-217

  4. Tumors of the thyroid gland. Proposal for the management and study of samples from patients with thyroid neoplasms

    Revista Espanola de Patologia, Vol. 53, Núm. 1, pp. 27-36

2019

  1. Newborn screening for homocystinurias: Recent recommendations versus current practice

    Journal of Inherited Metabolic Disease, Vol. 42, Núm. 1, pp. 128-139

  2. Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders—A successful strategy for clinical research of rare diseases

    Journal of Inherited Metabolic Disease, Vol. 42, Núm. 1, pp. 93-106

2018

  1. Correction to: Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders (Journal of Inherited Metabolic Disease, (2016), 39, 5, (661-672), 10.1007/s10545-016-9938-9)

    Journal of Inherited Metabolic Disease

  2. Correction to: Impact of age at onset and newborn screening on outcome in organic acidurias (Journal of Inherited Metabolic Disease, (2016), 39, 3, (341-353), 10.1007/s10545-015-9907-8)

    Journal of Inherited Metabolic Disease

  3. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway

    Modern Pathology, Vol. 31, Núm. 8, pp. 1168-1179

  4. Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 539-545

  5. New WHO classification of thyroid tumors: a pragmatic categorization of thyroid gland neoplasms

    Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 3, pp. 133-135

  6. Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

    Surgical Infections, Vol. 18, Núm. 8, pp. 846-853

  2. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE)

    Virchows Archiv, Vol. 470, Núm. 5, pp. 517-525

  3. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

    World Journal of Emergency Surgery

  4. Hobnail variant of papillary thyroid carcinoma: Clinicopathologic and molecular evidence of progression to undifferentiated carcinoma in 2 cases

    American Journal of Surgical Pathology, Vol. 41, Núm. 6, pp. 854-860

  5. Other rare tumours and tumour-like lesions

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 79-105

  6. Rare familial tumours

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 57-77

  7. Rare follicular tumours

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 27-44

  8. Rare papillary thyroid carcinomas

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 5-25